FDA Approves First OTC Continuous Glucose Monitor for Pediatric Use

The U.S. Food and Drug Administration has approved the first over-the-counter continuous glucose monitor for children aged two and older who do not use insulin. This device, Dexcom's Stelo Glucose Biosensor System, aims to help manage prediabetes in children by providing real-time glucose data.